Skip to main content
Eric Raabe, MD, Pediatric Hematology & Oncology, Baltimore, MD, Johns Hopkins Hospital

EricHuttonRaabeMD

Pediatric Hematology & Oncology • Baltimore, MD

Pediatric Neuro-Oncology

Associate Professor of Oncology, Instructor of Pathology, Johns Hopkins University School of Medicine

Join to view full profile

Dr. Raabe is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Raabe's full profile

Already have an account?

  • Office

    1800 Orleans St.
    The Charlotte R. Bloomberg Children's Center Building, 11th Floor
    Baltimore, MD 21287
    Phone+1 410-955-8751
  • Is this information wrong?

Summary

  • I am a board certified pediatric hematologist/oncologist focusing on pediatric brain tumors. In addition to clinical expertise, I lead a research group of post-doctoral fellows, graduate students, and laboratory assistants focused on investigating and disrupting key genetic pathways that drive the most aggressive pediatric brain tumors. We have research interests and on-going collaborations in diffuse intrinsic pontine glioma, glioblastoma, medulloblastoma, atypical teratoid/rhabdoid tumor, and aggressive low grade glioma. The discovery and deployment of new treatments for these high risk brain tumors is the focus of my research and clinical energies.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2007 - 2010
  • Children's Hospital of Philadelphia
    Children's Hospital of PhiladelphiaResidency, Pediatrics, 2003 - 2006
  • University of Cincinnati College of Medicine
    University of Cincinnati College of MedicineClass of 2003
  • Brown University
    Brown UniversityB.S., Neural Sciences, 1989 - 1993

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2007 - 2025
  • PA State Medical License
    PA State Medical License 2003 - 2006
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
  • Francis Schwentker Award for Excellence in Research Pediatrics House Staff and Fellows at Johns Hopkins, 2011
  • Alpha Omega Alpha University of Cincinnati College of Medicine, 2002
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Alterations in Cellular Metabolome after Pharmacological Inhibition of Notch in Glioblastoma Cells  
    Kahlert UD, Cheng M, Koch K, Marchionni L, Fan X, Raabe EH, Maciaczyk J, Glunde K, Eberhart CG, Int J Cancer, 1/30/2015
  • Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target  
    Weingart MF, Roth J, Hutt-Cabezas M , Busse T , Kaur H, Price A, Maynard R, Rubens J, Taylor I , Mao XG, Xu J, Kuwahara Y, Allen SJ , Erdreich-Epstein A, Weissman..., Oncotarget, 1/20/2015
  • The chromatin modifying protein HMGA2 promotes atypical teratoid rhabdoid cell tumorigenicity  
    Kaur, H, Hutt-Cabezas, M, Weingart, MF, Xu, J, Kuwahara, Y, Erdreich-Epstein, A, Weissman, B, Eberhart, CG, Raabe, EH, J Neuropathol Exp Neurol, 1/1/2015
  • Join now to see all

Press Mentions

  • Combination Drug Therapy for Childhood Brain Tumors
    Combination Drug Therapy for Childhood Brain TumorsApril 7th, 2020
  • Combination Drug Therapy for Childhood Brain Tumors Shows Promise in Laboratory Models: Researchers Say Findings Support Use in Clinical Trials
    Combination Drug Therapy for Childhood Brain Tumors Shows Promise in Laboratory Models: Researchers Say Findings Support Use in Clinical TrialsFebruary 17th, 2020
  • Inhibition of mTORC1 in Pediatric Low-Grade Glioma Depletes Glutathione and Therapeutically Synergizes with Carboplatin
    Inhibition of mTORC1 in Pediatric Low-Grade Glioma Depletes Glutathione and Therapeutically Synergizes with CarboplatinFebruary 14th, 2020
  • Join now to see all

Professional Memberships

Other Languages

  • French

Hospital Affiliations

External Links

Dr. Eric Raabe, Dr. Eric Raabe, MD, Dr. E Raabe, Dr. Eric Hutton Raabe